Barclays Starts Acacia Research (ACTG) at Equalweight, Sets $41 Price Target
Tweet
Share
E-mailGet Alerts ACTG Hot Sheet
Price: $4.68 +1.96%
Rating Summary:
7 Buy, 0 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
7 Buy, 0 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
An analyst at Barclays initiated coverage on shares of Acacia Research (NASDAQ: ACTG) with an Equalweight rating and a $41 price target Friday afternoon.
With the stock last trading down 1.7 percent to $38.14, the firm's new price target implies potential upside of about 7 percent.
For more ratings news on Acacia Research click here and for the rating history of Acacia Research click here.
With the stock last trading down 1.7 percent to $38.14, the firm's new price target implies potential upside of about 7 percent.
For more ratings news on Acacia Research click here and for the rating history of Acacia Research click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Barclays Upgrades Schott Pharma AG (1SXP:GR) to Overweight
- Goldman Sachs Starts Luxshare Precision (2475:HK) at Buy
- Truist Securities Reinstates Pacira Pharmaceuticals (PCRX) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
BarclaysSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
